NEW YORK, Aug 7, 2006 (PRIMEZONE via COMTEX News Network) -- The NASDAQ Stock Market, Inc. (Nasdaq:NDAQ) today announced that Steven Bloom has joined the organization as Senior Vice President of NASDAQ Financial Products. In this position, Dr. Bloom will oversee the development of new NASDAQ(r) indexes, financial products, and derivative securities, and the marketing of NASDAQ indexes and NASDAQ-sponsored exchange traded funds (ETFs). Dr. Bloom is also responsible for administering NASDAQ's index program, licensing structured products, and listing third-party sponsored ETFs.
Dr. Bloom reports to Executive Vice President and Chief Marketing Officer John Jacobs, who is also CEO of NASDAQ Global Funds - a subsidiary of NASDAQ.
Dr. Bloom was previously Principal of Capmark(r), a firm specializing in financial product design and strategic marketing in the investment industry. Dr. Bloom has been recognized for innovation and integrity in the field of financial services, particularly regarding the development and launch of ETFs, indexes, and derivative securities. Prior to joining NASDAQ, Dr. Bloom contributed significantly to the creation of the NASDAQ-100 Index Tracking Stock(r) (Nasdaq:QQQQ), the world's most actively traded ETF, and SPDRs(r) (Standard & Poor's Depositary Receipts(r)), the world's first and largest ETF as measured by assets under management. He holds a Ph.D. in economics from Harvard University, and has served as a securities industry arbitrator for both NASD and NYSE.
Commenting on Bloom's appointment, Jacobs said, "Steven brings to NASDAQ a wealth of expertise and a list of great accomplishments. NASDAQ will be well served by Steven's leadership, extensive experience, and innovation."
Dr. Bloom also contributed to the development of the NASDAQ-100 European Tracker(r) (Symbol: EQQQ), which is listed on markets in Germany, Italy, Switzerland, and the U.K. He previously served as new product advisor to The Bank of New York, whose four international stock indexes underly the ETF family of BLDRS (Baskets of Listed Depository Receipts(r); NASDAQ: ADRA; ADRD; ADRE; ADRU), and to J.P. Morgan Chase. In addition, he assisted in the launch of the first ETF offering by Fidelity Investments based on the NASDAQ Composite Index(r) (Nasdaq:ONEQ).
NASDAQ is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit http://www.nasdaqfacts.com or the NASDAQ Newsroom at http://www.nasdaq.com/newsroom/.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Dr. Bloom's role at NASDAQ; or the NASDAQ Indexes and NASDAQ-sponsored exchange traded funds (ETFs). We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ's control. These factors include, but are not limited to factors detailed in NASDAQ's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
This news release was distributed by PrimeZone, www.primezone.com
SOURCE: The Nasdaq Stock Market, Inc.
The NASDAQ Stock Market, Inc. Wayne Lee (301) 978-4875
(C) 2006 PRIMEZONE, All rights reserved.
News Provided by COMTEX